์ด๋ฆ„ ์—†๋Š” ๊ฒŒ์‹œํŒ#3

์ถœ์›์ผ

์ถœ์›๋“ฑ๋ก๋ฒˆํ˜ธ

์ถœ์›๋ช…์นญ

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

2021-05-13

PCT/KR2021/003965

ํด๋กœ์ŠคํŠธ๋ฆฌ๋””์˜ค์ด๋ฐ์Šค ๋””ํ”ผ์‹ค๋ฆฌ ๊ท ์— ๋Œ€ํ•˜์—ฌ ์šฉ๊ท  ํ™œ์„ฑ์„ ๊ฐ–๋Š” ํ–ฅ๊ท ๋‹จ๋ฐฑ์งˆ
(Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile)

Risk
assessment
analysis

Equipment
Work environment
Human risk

Education
and document
completion

Managing & determining the level of equipment

Monitoring

Deviation
Environmental monitoring

Product
quality
evaluation

Quality standards
Yield analysis

Improvement

Immediate measures to prevent issues Quality improvement Increase productivity

MICROBIOTIX CO., LTD

IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)  
TEL : 02. 6379. 2649
E-mail : mx@microbiotix.net

Copyright © MICROBIOTIX. All rights reserved.

INQUIRIES

MICROBIOTIX CO., LTD

IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)

TEL : 02. 6379. 2649   l   E-mail : mx@microbiotix.net

Copyright © MICROBIOTIX. All rights reserved.